Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,805,892
-$56,450 QoQ
Shares Held
4,987
-5.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,334
of 3,140 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aureus Asset Management, LLC holds $14,021,737 across 9 Drug Manufacturers - General names. AMGN ranks #3 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,359 | $4,028,885 | |
| 2 | JNJ |
Johnson & Johnson
|
9,201 | $2,336,777 | |
| 3 | AMGN |
Amgen Inc
This page
|
4,987 | $1,805,892 | |
| 4 | ABBV |
AbbVie Inc.
|
6,899 | $1,736,064 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,833 | $1,520,540 | |
| 6 | NVO |
Novo Nordisk A S
|
27,220 | $1,304,926 | |
| 7 | NVS |
Novartis AG
|
5,586 | $875,437 | |
| 8 | AZN |
Astrazeneca PLC
|
1,105 | $209,530 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,805,892 | 4,987 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,862,342 | 5,293 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,731,142 | 5,289 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,487,758 | 5,272 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,606,853 | 5,755 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,759,945 | 5,649 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $526,753 | 2,021 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $670,519 | 2,081 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $659,581 | 2,111 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $738,094 | 2,596 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $484,449 | 1,682 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $428,672 | 1,595 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $209,808 | 945 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $278,737 | 1,153 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $308,339 | 1,174 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $238,918 | 988 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $222,270 | 988 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $216,477 | 1,018 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,416,918 | 5,813 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,116,377 | 8,506 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,808,472 | 12,215 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,160,599 | 16,370 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,906,077 | 16,561 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,575,346 | 17,636 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||